• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刚果民主共和国金沙萨尼加利马公立医院住院的 COVID-19 患者的临床特征:一项回顾性队列研究。

Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: A retrospective cohort study.

机构信息

Clinique Ngaliema, Kinshasa, République Démocratique du Congo.

Département de Médecine Tropicale, Université de Kinshasa, Kinshasa, République Démocratique du Congo.

出版信息

PLoS One. 2020 Dec 18;15(12):e0244272. doi: 10.1371/journal.pone.0244272. eCollection 2020.

DOI:10.1371/journal.pone.0244272
PMID:33338063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7748279/
Abstract

OBJECTIVES

To describe the clinical characteristics of patients infected with SARS-CoV-2 at Clinique Ngaliema, a public hospital, in Kinshasa, in the Democratic Republic of Congo (DRC).

METHODS

This retrospective study analyzed medical records including socio-demographics, past medical history, clinical manifestation, comorbidities, laboratory data, treatment and disease outcome of 160 hospitalized COVID-19 patients, with confirmed result of SARS-CoV-2 viral infection.

RESULTS

The median age of patients was 54 years (IQR: 38-64), and there was no significant gender difference (51% of male). The most common comorbidities were hypertension (55 [34%]), diabetes (31 [19%]) and obesity (13 [8%]). Fever (93 [58%]), cough (92 [57%]), fatigue (87 [54%]), shortness of breath (72 [45%]) and myalgia (33 [21%]) were the most common symptoms, upon admission. Patients were categorized into mild (92 [57%]), moderate (19 [12%]) and severe (49 [31%]). Severe patients were older and were more likely to have comorbidities, compared to mild ones. The majority of patients (92% [147 of 160]) patients received hydroxychloroquine or chloroquine phosphate. Regression model revealed that older age, lower SpO2, higher heart rate and elevated AST at admission were all risk factors associated with in-hospital death. The prevalence of COVID-19 and malaria co-infection was 0.63% and 70 (44%) of all patients received antimalarial treatment before hospitalization.

CONCLUSION

Our findings indicated that the epidemiological and clinical feature of COVID-19 patients in Kinshasa are broadly similar to previous reports from other settings. Older age, lower SpO2, tachycardia, and elevated AST could help to identify patients at higher risk of death at an early stage of the illness. Plasmodium spp co-infection was not common in hospitalized COVID-19 patients.

摘要

目的

描述在刚果民主共和国(DRC)金沙萨的公立医院 Ngaliema 诊所感染 SARS-CoV-2 的患者的临床特征。

方法

这项回顾性研究分析了 160 名住院 COVID-19 患者的病历,包括社会人口统计学、既往病史、临床表现、合并症、实验室数据、治疗和疾病结局,这些患者的 SARS-CoV-2 病毒感染均得到确认。

结果

患者的中位年龄为 54 岁(IQR:38-64),且无明显的性别差异(51%为男性)。最常见的合并症是高血压(55 [34%])、糖尿病(31 [19%])和肥胖症(13 [8%])。入院时最常见的症状是发热(93 [58%])、咳嗽(92 [57%])、乏力(87 [54%])、呼吸急促(72 [45%])和肌痛(33 [21%])。患者被分为轻症(92 [57%])、中度(19 [12%])和重症(49 [31%])。与轻症患者相比,重症患者年龄更大,且更有可能合并症。大多数患者(92% [147 例/160 例])接受了羟氯喹或磷酸氯喹治疗。回归模型显示,入院时年龄较大、SpO2 较低、心率较快和 AST 升高均为与院内死亡相关的危险因素。COVID-19 和疟疾合并感染的患病率为 0.63%,且所有患者中有 70 例(44%)在住院前接受了抗疟治疗。

结论

我们的研究结果表明,金沙萨 COVID-19 患者的流行病学和临床特征与其他地区的先前报告大致相似。年龄较大、SpO2 较低、心动过速和 AST 升高可能有助于在疾病早期识别出死亡风险较高的患者。在住院 COVID-19 患者中,疟原虫合并感染并不常见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9165/7748279/a9b8de2a82ae/pone.0244272.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9165/7748279/b4f19ab1beb3/pone.0244272.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9165/7748279/3c62e9731a0a/pone.0244272.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9165/7748279/4aee84a1880d/pone.0244272.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9165/7748279/a9b8de2a82ae/pone.0244272.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9165/7748279/b4f19ab1beb3/pone.0244272.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9165/7748279/3c62e9731a0a/pone.0244272.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9165/7748279/4aee84a1880d/pone.0244272.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9165/7748279/a9b8de2a82ae/pone.0244272.g004.jpg

相似文献

1
Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: A retrospective cohort study.刚果民主共和国金沙萨尼加利马公立医院住院的 COVID-19 患者的临床特征:一项回顾性队列研究。
PLoS One. 2020 Dec 18;15(12):e0244272. doi: 10.1371/journal.pone.0244272. eCollection 2020.
2
Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo.非洲 COVID-19 住院患者的临床特征和结局:来自刚果民主共和国的早期观察。
Am J Trop Med Hyg. 2020 Dec;103(6):2419-2428. doi: 10.4269/ajtmh.20-1240. Epub 2020 Oct 2.
3
Characteristics, Treatment Outcomes and Role of Hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An Epidemio-Clinical Study.斋浦尔市522例COVID-19住院患者的羟氯喹特性、治疗结果及作用:一项流行病学临床研究
J Assoc Physicians India. 2020 Jun;68(6):13-19.
4
Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.中国武汉 116 例 COVID-19 住院患者的临床特征:一项以医院为中心、回顾性、观察性研究。
BMC Infect Dis. 2020 Oct 22;20(1):787. doi: 10.1186/s12879-020-05452-2.
5
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.氯喹或羟氯喹预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
6
Identifying risk factors for Plasmodium infection and anaemia in Kinshasa, Democratic Republic of Congo.确定刚果民主共和国金沙萨疟原虫感染和贫血的风险因素。
Malar J. 2016 Jul 15;15:362. doi: 10.1186/s12936-016-1412-5.
7
Predictors of mortality in COVID-19 patients at Kinshasa University Hospital, Democratic Republic of the Congo, from March to June 2020.2020 年 3 月至 6 月期间,刚果民主共和国金沙萨大学医院 COVID-19 患者的死亡预测因素。
Pan Afr Med J. 2020 Oct 1;37:105. doi: 10.11604/pamj.2020.37.105.25279. eCollection 2020.
8
Older Adults Hospitalized with Covid-19: Clinical Characteristics and Early Outcomes from a Single Center in Istanbul, Turkey.土耳其伊斯坦布尔一家医院收治的新冠肺炎老年患者:临床特征和早期结局。
J Nutr Health Aging. 2020;24(9):928-937. doi: 10.1007/s12603-020-1477-2.
9
Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.在新冠疫情早期,一家筛查诊所的冠状病毒病(COVID-19)病例的流行病学和临床特征:一项单中心研究。
J Med Microbiol. 2020 Aug;69(8):1114-1123. doi: 10.1099/jmm.0.001231.
10
Current malaria infection, previous malaria exposure, and clinical profiles and outcomes of COVID-19 in a setting of high malaria transmission: an exploratory cohort study in Uganda.在疟疾高传播地区,疟疾现症感染、既往疟疾暴露与 COVID-19 的临床特征和结局:乌干达的一项探索性队列研究。
Lancet Microbe. 2022 Jan;3(1):e62-e71. doi: 10.1016/S2666-5247(21)00240-8. Epub 2021 Oct 25.

引用本文的文献

1
Longitudinal kidney outcomes in surviving COVID-19 patients in Africa: a prospective Congolese single-center cohort study.非洲新冠病毒肺炎幸存者的肾脏纵向转归:一项刚果单中心前瞻性队列研究
Ren Fail. 2025 Dec;47(1):2514185. doi: 10.1080/0886022X.2025.2514185. Epub 2025 Jun 9.
2
Clinical Characteristics and Mortality Trends Among COVID-19 Patients During the First Four Waves in Ngaliema Clinic, Democratic Republic of the Congo.刚果民主共和国恩加利马诊所前四波新冠疫情期间新冠患者的临床特征及死亡率趋势
Infect Drug Resist. 2025 May 14;18:2525-2536. doi: 10.2147/IDR.S499371. eCollection 2025.
3
Mutations in ace2 gene modulate cytokine levels and alter immune responses in and SARS-CoV-2 co-infection: a Cameroonian cohort.

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
COVID19 and increased mortality in African Americans: socioeconomic differences or does the renin angiotensin system also contribute?新冠病毒与非裔美国人死亡率上升:社会经济差异还是肾素血管紧张素系统也有影响?
J Hum Hypertens. 2020 Nov;34(11):764-767. doi: 10.1038/s41371-020-0380-y. Epub 2020 Jul 15.
3
Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis.
血管紧张素转换酶2(ACE2)基因突变调节细胞因子水平并改变甲型流感病毒与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)合并感染时的免疫反应:喀麦隆队列研究
Front Immunol. 2025 Mar 24;16:1533213. doi: 10.3389/fimmu.2025.1533213. eCollection 2025.
4
Interest of Chest CT to Assess the Prognosis of SARS-CoV-2 Pneumonia: An In-Hospital-Based Experience in Sub-Saharan Africa.胸部CT对评估新型冠状病毒肺炎预后的价值:撒哈拉以南非洲地区的一项基于医院的经验
Pulm Med. 2024 Apr 25;2024:5520174. doi: 10.1155/2024/5520174. eCollection 2024.
5
Predictors of mortality among inpatients in COVID-19 treatment centers in the city of Butembo, North Kivu, Democratic Republic of Congo.刚果民主共和国北基伍省布滕博市新冠病毒治疗中心住院患者的死亡预测因素
PLOS Glob Public Health. 2024 Jan 24;4(1):e0002020. doi: 10.1371/journal.pgph.0002020. eCollection 2024.
6
Demographic characteristics, clinical presentation and in-hospital outcome among patients with Covid-19 in a Nigerian tertiary hospital.尼日利亚一家三级医院的新冠病毒患者的人口统计学特征、临床表现和住院结局。
Malawi Med J. 2023 Mar;35(1):43-57. doi: 10.4314/mmj.v35i1.8.
7
Splenic Infarction Secondary to COVID-19 and Malaria Co-Infection: A Case Report.新型冠状病毒肺炎与疟疾合并感染继发脾梗死:一例报告
Iran J Parasitol. 2023 Jul-Sep;18(3):400-403. doi: 10.18502/ijpa.v18i3.13763.
8
Risk factors for death in hospitalized COVID-19 patients in Africa: A systematic review and meta-analysis.非洲住院 COVID-19 患者死亡的风险因素:系统评价和荟萃分析。
Medicine (Baltimore). 2023 Sep 1;102(35):e34405. doi: 10.1097/MD.0000000000034405.
9
Co-infection of COVID-19 and parasitic diseases: A systematic review.新型冠状病毒肺炎与寄生虫病的合并感染:一项系统综述。
Parasite Epidemiol Control. 2023 May;21:e00299. doi: 10.1016/j.parepi.2023.e00299. Epub 2023 Mar 30.
10
Prevalence of SARS-CoV-2 and co-infection with malaria during the first wave of the pandemic (the Burkina Faso case).新冠病毒(SARS-CoV-2)和疟疾合并感染在疫情第一波期间的流行情况(布基纳法索案例)。
Front Public Health. 2022 Dec 12;10:1048404. doi: 10.3389/fpubh.2022.1048404. eCollection 2022.
52 例白细胞计数升高的 COVID-19 患者的临床特征:一项回顾性分析。
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2279-2287. doi: 10.1007/s10096-020-03976-8. Epub 2020 Jul 10.
4
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.年龄和多种合并症预测 COVID-19 患者的死亡:意大利高血压学会 SARS-RAS 研究的结果。
Hypertension. 2020 Aug;76(2):366-372. doi: 10.1161/HYPERTENSIONAHA.120.15324. Epub 2020 Jun 22.
5
Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes.新加坡 COVID-19 疫情期间住院患者的社区获得性病毒性呼吸道感染:合并感染和临床结局。
J Clin Virol. 2020 Jul;128:104436. doi: 10.1016/j.jcv.2020.104436. Epub 2020 May 19.
6
Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis.心血管疾病作为新冠病毒感染风险增加及相关不良预后的生物标志物。
Biomark Med. 2020 Jun;14(9):713-716. doi: 10.2217/bmm-2020-0201. Epub 2020 May 19.
7
Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of retrospective studies.肝损伤与2019年冠状病毒病(COVID-19)重症感染相关:一项回顾性研究的系统评价和荟萃分析
Hepatol Res. 2020 Aug;50(8):924-935. doi: 10.1111/hepr.13510. Epub 2020 Jun 25.
8
Genetic susceptibility for COVID-19-associated sudden cardiac death in African Americans.非裔美国人中与新冠病毒相关的心源性猝死的遗传易感性。
Heart Rhythm. 2020 Sep;17(9):1487-1492. doi: 10.1016/j.hrthm.2020.04.045. Epub 2020 May 5.
9
Association Between Hypoxemia and Mortality in Patients With COVID-19.低氧血症与 COVID-19 患者死亡率的关系。
Mayo Clin Proc. 2020 Jun;95(6):1138-1147. doi: 10.1016/j.mayocp.2020.04.006. Epub 2020 Apr 11.
10
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China.中国 COVID-19 患者肝损伤标志物与死亡率的纵向关联。
Hepatology. 2020 Aug;72(2):389-398. doi: 10.1002/hep.31301.